Revelation Biosciences released FY2024 Q2 earnings on August 9, 2024 (EST) with actual revenue of USD 0 and EPS of USD 0

Brief Summary

Revelation Biosciences announced its fiscal second-quarter 2024 results, reporting zero revenue, a net loss of $8,389,819, and an earnings per share (EPS) of $0.

Impact of The News

Analysis of Revelation Biosciences’ Q2 2024 Financial Results